Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study

Helen Mackay, David G. Huntsman, Hal W. Hirte, Amit M. Oza, C. Blake Gilks, Marc Tischkowitz, James Carmichael, Karen A. Gelmon, Kenneth D. Swenerton, André Robidoux, Katia Tonkin, Mark Clemons, Rinat Yerushalmi, Euan Macpherson

2011-08-21

SCID: 54.1/z9hhfwac

Publication Details

DOI

10.1016/s1470-2045(11)70214-5

Publication Date

2011-08-21

Journal

Publisher

ISSN

Access Type

Author Information

Authors

Helen Mackay

David G. Huntsman

Hal W. Hirte

Amit M. Oza

C. Blake Gilks

Marc Tischkowitz

James Carmichael

Karen A. Gelmon

Kenneth D. Swenerton

André Robidoux

Katia Tonkin

Mark Clemons

Rinat Yerushalmi

Euan Macpherson

Download PDF